Sickle Cell Disease in Social Security Disability Evaluations: Report Release Webinar
Join the National Academies on Monday, February 2, for a public release webinar in support of our latest report which reviews the latest published scientific research and addresses best practices and patient experiences in the management and treatment of sickle cell disease (SCD).
Sickle cell disease (SCD), a group of inherited blood disorders affecting approximately 100,000 people in the United States, is a chronic, lifelong condition that affects every organ system in the body. Symptoms and complications can vary from mild to severe and include acute and chronic pain, acute chest syndrome, stroke, and organ damage. The cumulative burden of SCD-related health effects can significantly affect quality of life and the ability to regularly attend and participate fully in school and work.
The resulting report identifies the importance of recognizing the cumulative burden of SCD-related health effects over time across all body systems. The committee concluded that access to coordinated and comprehensive SCD care across the life course can lead to better outcomes.
During the public release webinar, selected members of the report committee will speak and answer questions from the audience.
Learn more on the event page.
When:
Monday, February 2, 2026, 10:00 AM - 11:00 AM (UTC-05:00) Eastern Time (US & Canada)
Where:
Attend virtually:
You will receive the relevant link(s) to attend virtually via email.